8.60
price up icon0.08%   0.02
after-market 시간 외 거래: 9.09 0.49 +5.70%
loading
전일 마감가:
$8.62
열려 있는:
$8.62
하루 거래량:
686.28K
Relative Volume:
0.80
시가총액:
$443.04M
수익:
$27.46M
순이익/손실:
$-46.05M
주가수익비율:
-9.1489
EPS:
-0.94
순현금흐름:
$-33.83M
1주 성능:
-3.72%
1개월 성능:
+1.61%
6개월 성능:
+82.39%
1년 성능:
+98.78%
1일 변동 폭
Value
$8.325
$8.69
1주일 범위
Value
$7.84
$9.21
52주 변동 폭
Value
$4.20
$9.21

Zevra Therapeutics Inc Stock (ZVRA) Company Profile

Name
명칭
Zevra Therapeutics Inc
Name
전화
(321) 939-3416
Name
주소
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Name
직원
69
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
ZVRA's Discussions on Twitter

ZVRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ZVRA 8.60 443.04M 27.46M -46.05M -33.83M -0.94
VRTX 467.12 119.83B 10.63B -479.80M -1.35B 13.33
REGN 762.38 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 567.35 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.83 24.08B 3.30B -501.07M 1.03B 11.54

Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-03-17 개시 Maxim Group Buy

Zevra Therapeutics Inc 주식(ZVRA)의 최신 뉴스

pulisher
02:24 AM

(ZVRA) Technical Pivots with Risk Controls - Stock Traders Daily

02:24 AM
pulisher
01:56 AM

ZVRA FY2024 EPS Forecast Decreased by Cantor Fitzgerald - MarketBeat

01:56 AM
pulisher
01:13 AM

What is William Blair's Forecast for ZVRA FY2024 Earnings? - MarketBeat

01:13 AM
pulisher
Nov 16, 2024

Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

Zevra testing beta blocker celiprolol for vEDS in Phase 3 US study - Ehlers-Danlos News

Nov 15, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Invests $833,000 in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

What is William Blair's Estimate for ZVRA FY2026 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Here's What Analysts Are Forecasting For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Third-Quarter Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Research Analysts Set Expectations for ZVRA FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Sees Large Decline in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 14, 2024
pulisher
Nov 14, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Given New $23.00 Price Target at Canaccord Genuity Group - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Q4 Earnings Forecast for ZVRA Issued By Roth Capital - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Zevra Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Zevra Therapeutics' SWOT analysis: rare disease drug maker's stock poised for growth - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Janney Montgomery Scott LLC Sells 127,755 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics’ Transformative Third Quarter 2024 - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics earnings missed by $0.28, revenue fell short of estimates - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Zevra Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 11, 2024

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Zevra Therapeutics Validates Key Clinical Scale for Niemann-Pick Disease Treatment Study | ZVRA Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Zevra Therapeutics Inc (ZVRA) Q3 2024: Everything You Need To Kn - GuruFocus.com

Nov 11, 2024
pulisher
Nov 08, 2024

International Assets Investment Management LLC Raises Position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

(ZVRA) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 07, 2024
pulisher
Nov 07, 2024

ZVRA stock touches 52-week high at $8.96 amid market rally - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives $20.83 Average PT from Analysts - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13 - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Zevra Therapeutics CEO to Present at Guggenheim Healthcare Conference | ZVRA Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Zevra Therapeutics (ZVRA) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Zevra Therapeutics Inc - GuruFocus.com

Nov 05, 2024
pulisher
Oct 31, 2024

Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024 - The Manila Times

Oct 31, 2024
pulisher
Oct 29, 2024

Earnings Preview: Zevra Therapeutics (ZVRA) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 29, 2024
pulisher
Oct 28, 2024

How To Trade (ZVRA) - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 24, 2024

Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury

Oct 24, 2024
pulisher
Oct 22, 2024

Will Zevra Gallop Or Saunter In Q3? - RTTNews

Oct 22, 2024
pulisher
Oct 17, 2024

Objective long/short (ZVRA) Report - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 17, 2024

Sanctuary Advisors LLC Makes New $474,000 Investment in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Zevra therapeutics director Corey Watton buys $3,957 in stock - Investing.com India

Oct 17, 2024
pulisher
Oct 16, 2024

Zevra therapeutics director Corey Watton buys $3,957 in stock By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 14, 2024

Zevra Stock Surges Close to 70% in 3 Months: Here's Why - MSN

Oct 14, 2024
pulisher
Oct 13, 2024

Brokerages Set Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Price Target at $20.83 - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Short Interest Up 25.7% in September - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Zevra Therapeutics (NASDAQ:ZVRA) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

A company insider recently bought 2,000 shares of Zevra Therapeutics Inc [ZVRA]. Should You Buy? - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - The Manila Times

Oct 10, 2024
pulisher
Oct 10, 2024

Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented - EIN News

Oct 10, 2024

Zevra Therapeutics Inc (ZVRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Zevra Therapeutics Inc 주식 (ZVRA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Clifton R. LaDuane
CFO & Treasurer
Jul 17 '24
Buy
6.77
2,000
13,540
18,469
Anderson Thomas
Director
Jul 16 '24
Buy
6.81
10,000
68,065
20,000
Bode John B
Director
Jul 12 '24
Buy
5.87
10,000
58,661
30,000
$19.00
price up icon 4.27%
$76.98
price up icon 1.23%
$39.53
price up icon 7.03%
$359.21
price down icon 0.88%
$187.76
price down icon 0.58%
$101.83
price up icon 2.00%
자본화:     |  볼륨(24시간):